What it’s essential know:

– OMNY Well being, the main healthcare ecosystem recognized for facilitating compliant, cross-sector information sharing, has launched a platform designed to help AI-driven well being know-how firms, reaffirming its dedication to democratizing well being information.

– QuantHealth and ArisGlobal are simply two of OMNY’s newest companions leveraging this new platform to help their organizational AI-driven wants. OMNY Well being’s Knowledge Community uniquely addresses Generative AI’s want for giant anonymized structured and unstructured digital well being report (EHR) datasets throughout numerous healthcare suppliers and affected person populations, additional cementing the platform’s place as offering the information infrastructure and rails for healthcare suppliers to collaborate and speed up the event and adoption of efficient AI options to advance healthcare.

Advancing Healthcare By way of AI: OMNY Well being Strategic Partnerships

OMNY Well being™ is revolutionizing the healthcare panorama with its nationwide information ecosystem, designed to foster partnerships that enhance scientific outcomes and improve affected person care. Spanning all 50 states and greater than 75 million affected person lives, the platform connects well being techniques, specialty well being networks, tutorial medical facilities, and built-in supply networks. By facilitating information sharing and analysis collaboration, OMNY Well being fuels innovation the place sufferers want it most.

An incredible instance of OMNY Well being’s impression is its collaboration with QuantHealth and ArisGlobal, two AI-driven companions making nice strides in bettering healthcare. QuantHealth, the main AI-driven scientific trial design firm, leverages a large dataset of 350 million sufferers to enhance scientific trial timelines, mitigate threat, and determine populations possible to reply to therapies. By way of OMNY Well being’s collaboration, QuantHealth’s pharmaceutical companions can speed up drug growth utilizing simulated scientific trials. This strategy delivers real-world proof by predicting scientific trial outcomes, drug efficacy, and affected person responses.

One other key companion is ArisGlobal, a frontrunner in pharmacovigilance, security monitoring and reporting techniques. With its LifeSphere® know-how, ArisGlobal goals to rework security sign validation and allow complete, proactive sign detection. OMNY Well being’s collaboration with ArisGlobal demonstrates a dedication to bettering healthcare by AI-driven security monitoring and reporting techniques.

These collaborations illustrate OMNY Well being’s dedication to accelerating numerous scientific trial enrollment and supporting analysis applications centered on saving lives and bettering affected person outcomes. The corporate’s information ecosystem, which displays greater than seven years of historic information and encompasses greater than 2 billion scientific notes from over 300,000 suppliers throughout greater than 200 specialties, serves as a centralized useful resource for all times sciences and healthcare supplier teams. This complete information layer permits well being tech firms to drive next-generation innovation and guarantee sufferers obtain the very best care.

“Our mission is to free information from silos so it may be shared, analyzed and remodeled into life-saving therapies and higher look after sufferers,” mentioned Mitesh Rao, CEO of OMNY Well being. “Life sciences organizations and suppliers typically wrestle with time and funds constraints that hinder their capability to study from their information. Our work to energy AI-driven platforms can unblock this course of by partnering with AI builders with information and instruments to speed up breakthrough therapies and monitor new therapies for security alerts to make sure affected person populations stay protected.”